US FDA announces emergency authorization for convalescent plasma to treat Covid-19

The US Food and Drug Administration issued an emergency use authorization for the use of convalescent plasma to treat Covid-19 on Sunday, saying the "known and potential benefits of the product outweigh the known and potential risks of the product."

source https://www.cnn.com/2020/08/23/health/covid-19-convalescent-plasma-eua-white-house/index.html